Translate this page into:
Rational use of antibiotics at primary & secondary healthcare facilities in district Panchkula, Haryana, North India: A cross-sectional study
For correspondence: Prof Madhu Gupta, Department of Community Medicine and School of Public Health, Postgraduate Institute of Medical Education and Research, Chandigarh 160 012, India e-mail: madhugupta21@gmail.com
-
Received: ,
Accepted: ,
Abstract
Background & objectives
Antimicrobial prescriptions by doctors are crucial in managing acute illnesses but contribute significantly to antimicrobial resistance if misused. This study aimed to assess the rational use of antibiotics in outpatient public healthcare settings in Panchkula, Haryana.
Methods
A cross-sectional study was conducted across 18 primary and two secondary healthcare facilities in the district of Panchkula, Haryana. Antimicrobial prescriptions (n=945) were assessed for comprehensiveness and rationality using the pretested and validated antimicrobial prescription assessment tool and standard treatment guidelines. World Health Organisation’s anatomic therapeutic chemical and defined daily dose index (WHOCC-ATC/DDD) was used to calculate defined daily dose (DDD) for adult prescriptions, and days of therapy (DOT) were calculated for paediatric patients. We used descriptive statistics to summarise the findings and chi-square test to compare the proportions of rational and irrational prescriptions.
Results
Of 945 antibiotic prescriptions, only 0.4 per cent (n=4) of prescriptions were comprehensive. Among prescriptions eligible for rationality assessment (n=647, 68.5%) antibiotic therapy was indicated in 44 per cent (n=285), of which only 3.5 per cent (n=33) were rational, 20.2 per cent (n=191) moderately rational and 76.3 per cent irrational (n=721). Irrational prescriptions were most common in respiratory (n=415, 95%), gastrointestinal (n=105, 92.9%), and dermatological (n=21, 76%) ailments. The completeness of the prescriptions was low, with information on dosage of antibiotics (n=265, 28%), laboratory investigations (n=331, 35%), diagnosis (n=94, 10%), and co-morbidities (n=96, 10%). The prescribed antibiotic doses exceeded the WHO-DDD recommendations, with irrational prescribing significantly higher among paediatric prescriptions (89.6%) as compared with adult prescriptions (74.3%; adjusted odds ratio 1.36, 95% confidence interval 1.1-1.7, P<0.001).
Interpretation & conclusions
Antibiotic prescriptions in primary and secondary care outpatient departments demonstrated widespread irrationality, highlighting the importance of implementing a comprehensive antimicrobial stewardship programme in these settings.
Keywords
Antibiotic prescriptions
antimicrobial stewardship
primary healthcare
rational use
secondary healthcare
The 68th World Health Assembly incorporated global efforts to combat antimicrobial resistance (AMR) through the global action plan on antimicrobial Resistance (GAP-AMR) in 20151. One of the strategic objectives of GAP-AMR was optimizing the use of antimicrobials in human and animal health1. High antimicrobial consumption is attributed to overprescribing, over-the-counter access, and online sales2. The existing evidence suggests antibiotics are frequently prescribed unnecessarily, e.g., upper respiratory tract infections, afebrile pharyngitis, or diarrhea3. The overuse of antibiotics occurs both at tertiary and primary care levels4, A study across 26 European countries reported a high rate [32.2 defined daily dose (DDD) per 1000 inhabitants] of antibiotic prescriptions in primary care in France and a low rate (10.0 DDD per 1000 inhabitants) in the Netherlands5. In Vietnam, Nguyen et al3 (2022) indicated an alarming (97%) consumption of antibiotics for acute respiratory infections in children visiting primary healthcare settings.
Overuse of antimicrobials contributes to the emergence of resistant bacterial strains. A systematic review by Bell et al6 reported a positive relationship between antibiotic consumption and resistance (OR 2.3, CI 2.2 to 2.5, P <0.001). The reported negative impact of AMR includes 20 per cent additional infections in the community, leading to increased utilisation of intensive care units and lengthy hospital stays7. It is evident that a higher bacterial disease burden leads to a higher risk of AMR; every time an antimicrobial prescription is given, the chances of developing antibiotic-resistant bacterial strains increase8. Studies have reported that India had witnessed a surge of 40 per cent increase in sales of antibiotics between 2005 and 20099. A recent study has reported a significant increase in the sale of non-child-appropriate formulation antibiotics during the COVID-19 pandemic, indicating an urgent need for antibiotic stewardship measures10. While these studies have documented national trends in antibiotic consumption using sales data or focused on tertiary care settings, there remains a critical gap regarding the actual prescribing behaviour of doctors at primary and secondary care level.
Antimicrobial stewardship programmes have been implemented globally for decades but are not very well-established in primary and secondary health settings. India’s AMR policy (2011), and National Action Plan on Antimicrobial Resistance (NAP-AMR) is a decisive step taken by the Government of India to curb antimicrobial resistance by rationalizing antibiotic use, increasing the use of diagnostic tests, strengthening infection control, and training in-service physicians and pharmacists11.While antibiotic overprescribing is a known challenge across all levels of healthcare, particular attention is needed at primary and secondary health levels, given their contribution to antibiotic consumption5. Scientific evidence from the inpatient settings of tertiary care hospitals using WHO core prescribing indicators is available12. There is a scarcity of data on the rationality of antimicrobial prescriptions in lower-tier public health facilities. These settings are often the first point of contact for many patients; therefore, play a critical role in shaping antibiotic use patterns in the community. Moreover, there is limited evidence evaluating whether antibiotics are being prescribed appropriately regarding clinical indication, dose, duration, and choice of drug, especially in routine practice. Addressing this evidence gap is critical, as inappropriate antimicrobial use at the community level may fuel resistance more rapidly and undermine broader AMR containment efforts. This study aimed to determine the rationality of antimicrobial prescriptions issued by medical doctors in public sector outpatient settings on key parameters such as indication, choice, dosage, frequency, and duration of antibiotics prescribed to patients using a validated assessment tool.
Materials & Methods
This cross-sectional study was conducted by the department of Community Medicine and School of Public Health, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India, from September 2021 to March 2022. The study was approved by the Institute Ethics Committee of PGIMER.
Study health facilities
All public health facilities representing the complete network of public sector primary and secondary healthcare facilities (excluding the district hospital) in Panchkula district, Haryana were included in the study. There were eight rural health and wellness centres (HWCs), 10 urban HWCs at primary care level, one rural community health centre (CHC) and one urban CHC at secondary care level in the study area.
Study population
The doctors practicing allopathy in the study health facilities were included in the study. Those who were not practicing allopathy (Ayush doctors) were excluded.
Sample size
The sample size was calculated13. Considering the expected prevalence of irrational prescriptions (assumed to be 50%)14,15, and desired precision or margin of error assumed to be 5 per cent, Accounting for 15 per cent non-response rate, the final required sample size was 884 prescriptions. Prescriptions were collected from multiple facilities as outlined above, introducing a potential clustering effect due to facility-level differences in prescribing practices. To account for this, we applied a design effect (Deff) of 2.0 as the intra-cluster correlation may be present but not precisely known13. As we used stratified random sampling technique with probability proportional to size (PPS) sampling we had assumed the design effect of 2 to estimate the final sample size.
Sampling technique
A total of 75,000 prescriptions (about 12500 per CHC, 3000 per rural HWC, 2500 per urban HWC) were estimated to be prescribed in these health facilities in a month, with approximately 45,000 (60%) prescriptions expected to contain at least one antimicrobial drug. These estimates were obtained through consultation with respective facility in charge and pharmacy logs at each site. We used stratified sampling technique to collect 295 prescriptions from three types of health facilities to meet the desired sample size. To ensure proportional representation, probability proportional to size (PPS) sampling16 was used to determine the number of prescriptions to be collected from each facility type, i.e., 148 from each CHC (n=2), 37 from each rural HWC (n=8), and 30 from each urban HWC (n=10) (Fig. 1). Trained researchers were posted at the pharmacy counter and approached every patient exiting with a prescription during regular OPD hours. Prescriptions that contained at least one oral or injectable antibiotic were included till the desired sample size for that facility was achieved. This approach does not constitute classical probability sampling from a fully defined sampling frame, as prescriptions were not selected from a centralised database. Instead, prescriptions were collected consecutively from eligible patients during routine OPD hours until the facility-specific target sample size was reached. This method assumes that the arrival of patients with antimicrobial prescriptions occurs randomly over the survey period, and that prescriptions collected early or late in the sampling window are not systematically different in prescribing characteristics. While this may introduce a risk of sampling bias, it is considered a pragmatic and acceptable approach in field-based health systems research17. Measures were taken to minimise provider awareness and influence by collecting prescriptions at the pharmacy counter post-consultation, without engaging prescribers directly.

- Flow diagram depicting probability proportional sampling technique used to select the prescriptions from primary and secondary care health facilities (n=20).
Operational definition of rational and irrational antimicrobial prescription
Antimicrobial prescriptions
Antimicrobial prescriptions means prescriptions having at least one antibiotic mentioned on it. Definition of rational/irrational use of antimicrobials given by the World Health Organisation (WHO) was used to define the study outcomes.
Rational prescription of antimicrobials
As per the WHO ‘Patients receive antimicrobials appropriate to their clinical needs, in doses that meet their own individual requirements, for an adequate time, and at the lowest cost to them and their community’18.
Irrational prescription of antimicrobials
Any antimicrobial use that does not align with the above definition. Common examples include use in non-bacterial conditions where antimicrobial drugs are not indicated, inappropriate dosage and duration of therapy, use of too many antimicrobials per patient without justification (poly-pharmacy), inappropriate route of administration (e.g., injections when oral formulations are sufficient) and failure to prescribe antimicrobial drugs in accordance with clinical guidelines.
Data collection methods
The researchers visited the study health facilities during the OPD hours. Antimicrobial prescriptions were collected at the exit from the patients after consultation with the medical officer at the pharmacy and photocopied. Patients coming to the pharmacy were explained the purpose of the study, and written informed consent was obtained before their prescription was photocopied for the study. The original prescriptions were handed back to the patients. Information on previous medical history, co-morbidities, and previous treatment history was also collected from the patients. A validated pretested antimicrobial prescription assessment tool (AmPAT) used in this study was developed and validated in a previous study to assess the rationality of the prescriptions19. AmPAT has two sections. In section A, comprehensiveness of the prescriptions is assessed using 26 items with a score ranging from 0 to 29 (Supplementary Material)19. Comprehensiveness categories were high (score=24-29), medium (score=21-23), and low (score < 21). Section B is a rationality assessment with 19 items. Scoring for rationality assessment ranged from 0 to 13, with high (11–13), moderate (8-10), and low (<8) categories. The mandatory criteria for the rationality assessment of the prescriptions were legibility, age, and presenting symptoms/diagnosis. AmPAT rationality assessment was based upon the antibiotics prescription protocols mentioned in the standard textbooks, national treatment guidelines (Government of India, 2016), standard treatment guidelines by recognised bodies, and Update20,21. About 10 per cent of prescriptions were validated by the expert group comprising faculty from the department of Pharmacology, Community Medicine, and Internal Medicine, at PGIMER Chandigarh, India.
Data management and analysis
Data were entered in MS Excel and analysed using statistical package for the social sciences (SPSS version 21.0; SPSS Inc., Chicago, Armonk, NY, USA) The primary outcomes were the proportion of antimicrobial prescriptions rational, comprehensive, appropriate in terms of necessary use, choice of antimicrobials, dosage and frequency of antimicrobials, appropriate instructions for follow-up, and poly-pharmacy. Days of therapy (DOT) were calculated for paediatric patients using standard methodology22. Defined daily doses per person were calculated for antimicrobial prescriptions for adult patients using the WHOCC-ATC/DDD Index23. Associations between categorical variables (e.g., age group, sex, facility type) and prescription rationality were examined using Pearson’s chi-square test. Where expected cell counts were less than five, Fisher’s exact test was applied. Results were reported as odds ratio (OR) with 95 per cent confidence intervals (CIs). Binary logistic regression model was used to identify significant factors associated with irrational antimicrobial prescriptions. The dependent categorical variable was whether a prescription was irrational or rational. The independent variables included patient age group, sex, education status, presenting ailment category (e.g., respiratory, gastrointestinal, dental, etc.), number of antibiotics prescribed per prescription, and whether diagnostic investigations were advised. (Supplementary Table). The model estimated adjusted OR with 95 per cent CIs. P<0.05 was considered statistically significant.
Results
The background characteristics of the patients (whose prescriptions were assessed) are given in table I. The median age of paediatric patients (n=125) and adult patients was 5 and 35 yr, respectively. Paediatric prescriptions had 1.36 times higher odds of being irrational compared to adult prescriptions,
| Parameter | Total prescriptions, n=945 (100%); n (%) | Rational prescriptions, n=224 (23.7%); n (%) | Irrational prescriptions, n=721 (76.3%); n (%) | Adjusted OR (95% CI) | P value |
|---|---|---|---|---|---|
| Gender | 0.80 | ||||
| Male | 415 (43.9) | 100 (24.1) | 315 (75.9) | Ref | |
| Female | 530 (56.1) | 124 (23.4) | 406 (76.6) | 1.2 (0.9-1.6) | |
| Age group | <0.001 | ||||
| Paediatric total | 125 (13.2) | 13 (10.4) | 112 (89.6) | 1.36 (1.1-1.7) | |
| Adults | 820 (86.8) | 211 (25.7) | 609 (74.3) | Ref | |
| Education status | <0.001 | ||||
| Age ineligible (<7 yr) | 96 (10.1) | 8 (8.3) | 88 (91.7) | ||
| Illiterate | 86 (9.1) | 14 (16.3) | 72 (83.7) | Ref | |
| Primary | 167 (17.6) | 37 (21.2) | 130 (77.8) | 1.1 (0.7-1.7) | |
| Secondary | 360 (38.1) | 101 (28.1) | 259 (71.9) | 1.5 (1.13-2.1) | |
| Higher secondary | 96 (10.2) | 25 (26) | 71 (74) | 1.4 (0.8-2.3) | |
| Graduation and above | 140 (14.8) | 39 (27.9) | 101 (72.1) | 1.5 (0.9-2.3) |
P values were calculated using multivariate binary logistic regression. OR, Odds ratio; Ref, reference category; CI, confidence interval
A total of 945 prescriptions were collected from CHCs (n=297), rural HWCs (n=298), and urban HWCs (n=350). Four out of 945 (0.4%) prescriptions were found to be in the medium category of comprehensiveness, and 941/945 in low category as per the scoring criteria. The lack of comprehensiveness was mainly due to incomplete recording of the information required for antibiotic rationality assessment including dose of antibiotic (680/945,72%), lab investigations (614/945, 65%), diagnoses (851/945, 90%), and co-morbidities (849/945, 90%). Only 647/945 (68%) of prescriptions had the symptoms or diagnosis recorded on them (Fig. 2).

- Proportion (%) of prescriptions reporting key information items as per AmPAT indicators (n=945).
Among the prescriptions that had sufficient information to assess rationality (647/945), antibiotic therapy was clinically indicated in 44 per cent (285/647). However, within these prescriptions, 31 per cent (199/647) lacked correct information on dosage (either it was missing or inaccurate). Based on the rationality scoring criteria (maximum score 13), only 3.5 per cent (33/945) of prescriptions scored above 11, 20.2 per cent (191/945) scored between 8-10, and 76.3 per cent (721/945) scored below 8. Information regarding drug interactions, follow up visits, and instructions regarding the consumption of antibiotics was not mentioned in any prescription (Fig. 3).

- Flow diagram of rationality assessment using Antimicrobial Prescription Assessment Tool (n=945).
The most common symptoms patients presented with were respiratory ailments (46%), followed by dental problems and gastrointestinal diseases (n=113, 12%; Table II). Irrationality was reported in prescriptions irrespective of the presenting symptoms (Range 38.8%-100%). Patients who were advised only medicines without diagnostic tests had 1.72 times higher odds of receiving irrational prescriptions (OR 1.72, 95% CI 1.23-2.41, P=0.02) suggesting that lack of diagnostic support may contribute to inappropriate antibiotic use. Amoxicillin (n=302, 32%) was the most prescribed antibiotic, followed by fluoroquinolones (n=252, 27%), macrolides (n=209, 22%), and cephalosporins (n=87, 9%). The majority (99%) of the antibiotics were prescribed by generic name. Prescriptions containing combination drugs such as amoxicillin-clavulanic acid or ofloxacin-ornidazole were prescribed to 6.5 per cent of patients and had greater odds of being irrational (aOR 1.1, 95% CI 0.9-1.3). Irrational prescriptions were maximum in respiratory (95.4%), gastrointestinal (92.9%), and dermatological cases (77.8%; Table II).
| Variable | Total prescriptions n=945 (100%); n (%) | Rational prescriptions n=224 (23.7%); n (%) | Irrational prescriptions n=721 (76.3%); n (%) | Adjusted OR (95% CI) | P value |
|---|---|---|---|---|---|
| Ailment | <0.001 | ||||
| Respiratory | 435 (46) | 20 (4.6) | 415 (95.4) | Ref | |
| Dental | 231 (24.4) | 120 (51.9) | 111 (48.1) | 4.1 (3.1-5.4) | |
| Gastrointestinal | 113 (12) | 8 (7.1) | 105 (92.9) | 0.3 (0.2-0.6) | |
| Febrile illness | 49 (5.2) | 30 (61.2) | 19 (38.8) | 4.9 (2.8-8.5) | |
| Gynaecological | 46 (4.9) | 26 (56.5) | 20 (43.5) | 5.8 (3.1-10.7) | |
| Dermatological | 27 (2.8) | 6 (22.2) | 21 (77.8) | 1.1 (0.5-2.8) | |
| Trauma/injury | 24 (2.5) | 14 (58.3) | 10 (41.7) | 5.3 (2.3-11.9) | |
| Ophthalmological | 11 (1.2) | 0 (0) | 11 (100) | ||
| Musculoskeletal | 9 (0.8) | 0 (0) | 9 (100) | ||
| Type of antibiotics prescribed by the doctors | <0.001 | ||||
| Penicillin | 302 (32) | 93 (30.8) | 209 (69.2) | Ref | |
| Fluoroquinolones | 252 (26.7) | 91 (36.1) | 161 (63.9) | 2.1 (1.6-2.8) | |
| Macrolides | 209 (22) | 12 (5.7) | 197 (94.3) | 0.2 (0.1-0.4) | |
| Cephalosporins | 87 (9.2) | 12 (13.8) | 75 (86.2) | 0.6 (0.3-1.1) | |
| Nitroimidazoles | 48 (5) | 1 (2.1) | 47 (97.9) | 0.08 (0.01-0.6) | |
| Tetracyclines | 46 (5) | 15 (32.6) | 31 (67.4) | 1.82 (0.9-3.4) | |
| Sulphonamides | 1 (0.1) | 0 (0) | 1 (100) | ||
| Advise by the doctor | 0.02 | ||||
| Medicines only | 625 (66.1) | 168 (26.9) | 457 (73.1) | 0.8 (0.6-1.1) | |
| Investigations & medicines | 318 (33.7) | 56 (44.8) | 262 (82.4) | Ref | |
| Investigations & follow up with reports | 2 (0.2) | 0 (0) | 2 (100) | - | |
| Number of antibiotics per prescription | <0.001 | ||||
| 1 | 820 (86.8) | 168 (20.5) | 652 (79.5) | Ref | |
| 2 | 125 (13.2) | 56 (44.8) | 69 (55.2) | 3.1 (2.1-4.4) | |
| Number of combination drugs (antibiotics with more than one salts) prescribed | 61 (6.5) | 22 (36.1) | 39 (63.9) | 1.11 (0.9-1.3) | |
P values were calculated using multivariate binary logistic regression
Table III shows doctors’ prescribing patterns according to the respective ailment. Maximum irrationality was reported in the prescriptions for respiratory ailments (93%), followed by gastrointestinal (91%) and dermatology (71%). It was observed that macrolides (azithromycin), followed by amoxicillin/amoxicillin-clavulanic acid, were the most prescribed antibiotics to patients with respiratory ailments.
| Ailments | Respiratory, n (%) | Dental, n (%) |
Gastrointestinal, n (%) |
AFI, n (%) |
Gynaecology, n (%) |
Dermatological, n (%) |
Trauma, n (%) |
Ophthalmological, n (%) |
Musculoskeletal, n (%) |
|---|---|---|---|---|---|---|---|---|---|
| Macrolides | 199 (45.7) | 1 (0.4) | 1 (0.9) | 7 (14.3) | 1 (2.2) | 0 | 0 | 0 | 0 |
| Penicillin | 152 (34.9) | 93 (34.9) | 4 (3.5) | 23 (46.9) | 5 (10.9) | 7 (25.9) | 14 (58.3) | 0 | 4 (44.4) |
| Cephalosporins | 50 (11.5) | 3 (1.3) | 10 (8.8) | 14 (28.6) | 4 (8.7) | 3 (11.1) | 3 (12.5) | 0 | 0 |
| Fluoroquinolones | 20 (4.6) | 125 (54.1) | 56 (49.6) | 5 (10.2) | 17 (37) | 10 (37) | 5 (20.8) | 10 (90.9) | 4 (44.4) |
| Nitroimidazoles | 1 (0.2) | 3 (1.3) | 41 (36.3) | 0 | 2 (4.3) | 0 | 1 (4.2) | 0 | 0 |
| Sulphonamides | 1 (0.2) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tetracyclines | 12 (2.8) | 6 (2.6) | 1 (0.9) | 0 | 17 (37) | 7 (25.9) | 1 (4.2) | 1 (9.1) | 1 (11.1) |
| Total | 435 (100) | 231 (100) | 113 (100) | 49 (100) | 46 (100) | 27 (100) | 24 (100) | 11 (100) | 9(100) |
The duration of therapy and range of defined daily doses were analysed in older (n=163) and paediatric age group prescriptions (n=125) for various illnesses and antibiotics. The DDD observed did not align with the WHO’s recommendations for all prescribed antibiotics. The duration of therapy was inappropriate for amoxicillin, azithromycin, and cefadroxil when the patient presented with respiratory symptoms (Table IV).
| Antibiotic | Duration of therapy (range), days | Range of DDD observed in the study in g (mean±SD) | WHO recommended DDD per patient (g) |
|---|---|---|---|
| Age >12 yr (n=163) | |||
| Doxycycline (n=37) | 1-7 | 2-14 (5.19±2.78) | 0.1 |
| Amoxicillin (n=34) | 3-5 | 1.67-5 (3.06±2.48) | 1.5 |
| Ciprofloxacin (n=34) | 3-5 | 1.5-5 (2.89±2.25) | 1.0 |
| Azithromycin (n=20) | 3-10 | 3-10 (4.1±2.3) | 0.5 |
| Ofloxacin (n=16) | 3-5 | 3-6 (3.6±2) | 0.4 |
| Cefixime (n=13) | 3-5 | 3-5 (4.53±1.86) | 0.4 |
| Amoxicillin+clavulanic acid (n=6) | 3-7 | 2.5-4.17 (3.5±2.5) | 1.5 |
| Metronidazole (n=3) | 5 | 2.4-2.67 (2.58±2) | 1.5 |
| Age<12 yr (n=125) | |||
| Respiratory ailment (n=93) | - | - | |
| Amoxicillin/Amoxicillin-clavulanic acid (n=52) | 8-20 | - | - |
| Azithromycin (n=33) | 5-17 | - | - |
| Cefadroxil (n=5) | 5-10 | - | - |
| Cefixime (n=2) | 7 | - | - |
| Ofloxacin (n=1) | 3-5 | - | - |
| Metronidazole (n=4) | 5-7 | - | - |
| Cefixime (n=2) | 5 | - | - |
| Norfloxacin (n=1) | 5 | - | - |
| Dental Ailments (n=7) | - | - | |
| Amoxicillin (n=5) | 5-10 | - | - |
| Ciprofloxacin (n=1) | 5 | - | - |
| Cefixime (n=1) | 5 | - | - |
| Dermatological ailment (n=5) | - | - | |
| Amoxicillin (n=1) | 7 | - | - |
| Cefixime (n=1) | 5 | - | - |
| Ofloxacin (n=1) | 5 | - | - |
| Ciprofloxacin (n=1) | 5 | - | - |
| Cefadroxil (n=1) | 5 | - | - |
| Others (n=11) | - | - | |
| Amoxicillin (n=11) | 5-10 | - | - |
WHO, World Health Organization
Discussion
This study provided evidence on the antibiotic prescribing practices of generalist medical doctors in primary and secondary healthcare facilities to identify current practice gaps, which have implications on the rationality of antimicrobial use on antimicrobial resistance. The high proportion (76.3%) of irrational antibiotic prescriptions at primary and secondary healthcare facilities indicates an urgent need for implementing antimicrobial stewardship programmes in primary and secondary healthcare settings in low- and middle-income countries, including India.
The high proportion of irrational antibiotic prescriptions reported by our study is consistent with existing scientific literature. A study conducted in public health facilities in Pakistan (2018) reported a very high irrational antibiotic prescription rate (83.6%)24, while an Ethiopian study found 86.6 per cent25. In India, Kotwani et al26 (2012) reported inappropriate antibiotic prescribing in the public sector (43%) and private sector (69%) by family physicians. Our study has reported that 31.5 per cent of prescriptions were ineligible for rationality assessment, with diagnosis missing 90 per cent of the prescriptions. Similarly, an Ethiopian study (2013) highlighted missed diagnoses in 99 per cent of prescriptions27. The incompleteness of the prescriptions led to low rationality as information like diagnosis is necessary to assess whether the prescribed antibiotic is correct.
The proportion of irrational prescriptions was significantly higher among paediatric patients (89.6%) as compared with the adults (74.3%) (P<0.001) in this study. Antibiotics were frequently prescribed for conditions like upper respiratory tract infections or diarrhoea, which are unnecessary. A systematic review (2014) reported that treatment errors are more common among paediatric patients28. Studies indicate irrational antibiotic treatment is prevalent in cough, cold, or diarrhoea cases. A study in Iran (2023) reported that 60 per cent of prescriptions did not meet scientific criteria for antibiotic prescribing29. Similarly, Kotwani et al26 (2012) reported that at least one antibiotic was prescribed to children with diarrhoea at public health facilities, with higher rates in the private sector (69%) than in the public sector (65%). Between 2000 and 2015, the defined daily doses (DDD) calculated to assess antibiotic consumption had increased by 65 per cent30. If the policies remain unchanged, consumption can increase by up to 200 per cent by 203030. Low- and middle-income countries significantly drive this alarming consumption rate30. The DDD of all the antibiotics prescribed in our study was high compared to the DDD recommended by WHO23. Our study reported antibiotic prescribing practices for respiratory infections, diarrhoea, skin, and soft tissue infections, which were not in line with national treatment guidelines21, similar to the study conducted in Ujjain, India31.
The lack of adequate laboratory facilities at the primary healthcare level is a significant contributor to the irrational antibiotic prescribing practice. Our study reported low use (33%) of laboratory diagnostic measures, which could be one of the factors in primary healthcare physicians’ irrational antibiotic practices in the district of Panchkula, Haryana. A qualitative study by Kotwani et al32 revealed that diagnostic uncertainty about whether the infection is bacterial or viral leads to irrational antibiotic prescribing. Providing basic diagnostic test facilities or promoting point-of-care testing at primary healthcare facilities could help in making better diagnoses and lead to better prescribing practices.
The use of broad-spectrum antibiotics like cephalosporins at primary healthcare facilities is another cause of concern. More than 10 per cent of prescriptions had cephalosporins in respiratory or gastrointestinal ailments, which are not recommended as per the national treatment guidelines. Increased use of cephalosporins is leading to an increase in resistant strains of various organisms, and in case of continuation, it might lead to a rise in antimicrobial resistance33.
The strength of this study lies in its unique approach. In contrast to retrospective analyses based on electronic databases or pharmacy sales records, the real-time prescription data collection approach employed in this study offers several methodological advantages. It facilitates the capture of complete prescription information, including clinical details and medications that may not have been dispensed, elements often absent in routine health information systems. This approach also enables the application of validated assessment tools such as AmPAT, which require contextual data on diagnosis, dosage, duration, and treatment indication to determine the rationality of antimicrobial use, information typically unavailable in secondary data sources. The objective of this study was to evaluate the clinical rationality and appropriateness of antimicrobial prescriptions in real-world primary and secondary care settings, which required a more granular, prescription-level assessment tool. Therefore, AmPAT was selected for its ability to comprehensively assess the rationality of prescribing practices at the point of care.
We recognise the potential for observer effect (Hawthorne effect), whereby prescribers may modify their behaviour in the presence of data collectors, potentially leading to an underestimation of irrational prescriptions. To minimise this, prescriptions were collected passively at the pharmacy counter without direct interaction with clinicians. In contrast, database-based analyses, while free from this observer bias, often lack key clinical and diagnostic information required to assess rationality, especially in public sector settings without electronic health records. The choice of real-time prescription assessment was guided by the objective of capturing prescribing behaviour as it occurs in routine settings, while enabling a comprehensive evaluation of appropriateness, indication, and completeness, which is not feasible through databases alone. The study data were collected from rural and urban primary healthcare settings to be more representative of the population in the different settings and increase the generalisability of the findings. This study presents the data for antibiotic prescribing patterns for all kinds of infections in outpatient primary and secondary healthcare settings, unlike other studies that reported data on one or two diseases, such as upper respiratory tract infections or diarrhoea. However, no data on the experience of the prescriber were collected. There were few limitations of this study. Firstly, the prescription was collected directly from the patient, and no information regarding the doctor’s justification for prescribing antibiotics was recorded. Secondly, the social desirability bias cannot be ruled out due to the presence of researchers in health facilities affecting the behaviour of doctors. The use of consecutive sampling, while operationally feasible, might introduce selection bias if the arrival of patients is not truly random over time. Data were collected over multiple days to help mitigate this risk.
Our findings highlight a critical gap in the rational use of antimicrobials at the first point of care and underscore the urgent need for context-specific standard treatment guidelines (STGs) tailored to the primary healthcare level. There is a compelling need to develop tier-specific antimicrobial prescribing guidelines that reflect the clinical realities and resource constraints at different levels of the healthcare system, including those low-resource, high-volume settings. These should be supported by regular in-service training, point-of-care diagnostic tools, and prescription audit-feedback mechanisms. The adoption of standardised prescription templates or digital tools may further improve prescribing practices and documentation quality. District health authorities should establish routine prescription audits and community-based surveillance systems, led by antimicrobial stewardship committees with representation across primary, secondary, and tertiary levels. These measures are essential to promote rational antimicrobial use and curb the spread of antimicrobial resistance.
Financial support & sponsorship
None.
Conflicts of Interest
None.
Use of Artificial Intelligence (AI)-Assisted Technology for manuscript preparation
The authors confirm that there was no use of AI-assisted technology for assisting in the writing of the manuscript and no images were manipulated using AI.
References
- World Health Organization. Global action plan on antimicrobial resistance. Available from: https://www.who.int/data/gho/data/themes/antimicrobial-resistance-(amr), accessed on June 23, 2025.
- The use of non-prescribed antibiotics; prevalence estimates in low-and-middle-income countries: a systematic review and meta-analysis. Arch Public Health. 2021;79:2.
- [CrossRef] [PubMed] [PubMed Central] [Google Scholar]
- Outpatient antibiotic prescribing for acute respiratory infections in Vietnamese primary care settings by the WHO AWaRe (Access, Watch and Reserve) classification: an analysis using routinely collected electronic prescription data. Lancet Reg Health West Pac. 2022;30:100611.
- [CrossRef] [PubMed] [PubMed Central] [Google Scholar]
- Antibiotic prescribing in public and private practice: a cross-sectional study in primary care clinics in Malaysia. BMC Infect Dis. 2016;16:208.
- [CrossRef] [PubMed] [PubMed Central] [Google Scholar]
- Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet. 2005;365:579-87.
- [CrossRef] [PubMed] [Google Scholar]
- A systematic review and meta-analysis of the effects of antibiotic consumption on antibiotic resistance. BMC Infect Dis. 2014;14:13.
- [CrossRef] [PubMed] [PubMed Central] [Google Scholar]
- The negative impact of antibiotic resistance. Clin Microbiol Infect. 2016;22:416-22.
- [CrossRef] [PubMed] [Google Scholar]
- The relationship between the volume of antimicrobial consumption in human communities and the frequency of resistance. Proc Natl Acad Sci USA. 1999;96:1152-6.
- [CrossRef] [PubMed] [PubMed Central] [Google Scholar]
- Rationalizing antibiotic use to limit antibiotic resistance in India. Indian J Med Res. 2011;134:281-94.
- [PubMed] [PubMed Central] [Google Scholar]
- Sales of antibiotics and hydroxychloroquine in India during the COVID-19 epidemic: an interrupted time series analysis. PLoS Med. 2021;18:e1003682.
- [CrossRef] [PubMed] [PubMed Central] [Google Scholar]
- National Centre for Disease Control. Directorate General of Health Services, Ministry of Health & Family Welfare. Government of India. National action plan on AMR (NAP-AMR). Available from: https://www.ncdc.gov.in/WriteReadData/linkimages/AMR/File645.pdf, accessed on June 16, 2025.
- Assessment of drug prescribing pattern using world health organization indicators in a tertiary care teaching hospital. Indian J Public Health. 2018;62:156-8.
- [CrossRef] [PubMed] [Google Scholar]
- Sample size, power and effect size revisited: Simplified and practical approaches in pre-clinical, clinical and laboratory studies. Biochem Med (Zagreb). 2021;31:010502.
- [CrossRef] [PubMed] [PubMed Central] [Google Scholar]
- Patterns of antibiotic use in the community and challenges of antibiotic surveillance in a lower-middle-income country setting: a repeated cross-sectional study in Vellore, South India. J Antimicrob Chemother. 2013;68:229-36.
- [CrossRef] [PubMed] [Google Scholar]
- General practitioners’ prescribing patterns at primary healthcare centers in national health insurance, Gezira, Sudan. Drugs Real World Outcomes. 2016;3:327-32.
- [CrossRef] [PubMed] [PubMed Central] [Google Scholar]
- Sampling techniques (3rd ed). New York: John Wiley Sons; 1977.
- Monitoring Antibiotic use in public health care facilities of South Indian Union Territory: a step to promote rational use of antibiotics. Cureus. 2021;13:e18431.
- [CrossRef] [PubMed] [PubMed Central] [Google Scholar]
- The rational use of drugs: report of the conference of experts. Nairobi, 25-29 November 1985. Geneva: WHO; 1985.
- Antimicrobial Prescription Assessment Tool (AmPAT) development and validation for assessing the rationality of antimicrobial prescriptions in primary and secondary healthcare settings in India. Public Health. 2025;238:7-15.
- [CrossRef] [PubMed] [Google Scholar]
- UpToDate [Homepage internet]. Available from: https://www.uptodate.com/contents/search, accessed on June 16, 2025.
- National Centre for Disease Control. Directorate General of Health Services. Ministry of Health and Family Welfare. Government of India. National treatment guidelines for antimicrobial use in infectious diseases syndrome. Available from: https://ncdc.gov.in/WriteReadData/l892s/File622.pdf, accessed on June 16, 2025.
- Centers for Disease Control and Prevention. National Healthcare Safety Network. Antimicrobial use and resistance (AUR) module. Available from: http://www.cdc.gov/nhsn/PDFs/pscManual/11pscAURcurrent.pdf, accessed on June 23, 2025.
- World Health Organization. The anatomical therapeutic chemical classification system with defined daily doses-ATC/DDD. Available from: https://www.who.int/standards/classifications/other-classifications/the-anatomical-therapeutic-chemical-classification-system-with-defined-daily-doses, accessed on June 16, 2025.
- Antimicrobial use by WHO methodology at primary health care centers: a cross sectional study in Punjab, Pakistan. BMC Infect Dis. 2018;18:492.
- [CrossRef] [PubMed] [PubMed Central] [Google Scholar]
- Antibiotic prescribing practice in the management of cough or diarrhea among children attending hospitals in Addis Ababa: a cross-sectional study. Pediatric Health Med Ther. 2017;8:93-8.
- [CrossRef] [PubMed] [PubMed Central] [Google Scholar]
- Antibiotic-prescribing practices of primary care prescribers for acute diarrhea in New Delhi, India. Value Health. 2012;15:S116-9.
- [CrossRef] [PubMed] [Google Scholar]
- Assessment of drug use practices and completeness of prescriptions in Gondar University Teaching Referral Hospital. Int J Pharm Sci Res. 2013;4:265.
- [Google Scholar]
- Interventions to reduce pediatric medication errors: a systematic review. Pediatrics. 2014;134:338-60.
- [CrossRef] [PubMed] [Google Scholar]
- Prescribing pattern of antibiotics by family physicians in primary health care. J Pharm Policy Pract. 2023;16:11.
- [CrossRef] [PubMed] [PubMed Central] [Google Scholar]
- Global increase and geographic convergence in antibiotic consumption between 2000 and 2015. Proc Natl Acad Sci USA. 2018;115:E3463-70.
- [CrossRef] [PubMed] [PubMed Central] [Google Scholar]
- Antibiotic prescribing in outpatients: hospital and seasonal variations in Ujjain, India. Scand J Infect Dis. 2011;43:479-88.
- [CrossRef] [PubMed] [Google Scholar]
- Factors influencing primary care physicians to prescribe antibiotics in Delhi India. Fam Pract. 2010;27:684-90.
- [CrossRef] [PubMed] [Google Scholar]
- Establishing a new methodology for monitoring of antimicrobial resistance and use in the community in a resource poor-setting. J Appl Ther Res. 2009;7:37-45.
- [Google Scholar]
